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Yerba Maté (Illex Paraguariensis) ingestion
augments fat oxidation and energy expenditure
during exercise at various submaximal intensities
Ahmad Alkhatib1,2
Abstract
Background: Ingesting Yerba Maté (YM) has become widely popular for health promotion, obesity prevention and
body weight reduction, primarily due its thermogenic effectiveness. However, the YM effects on fat metabolism
during exercise, when fat metabolism is already increased several fold, are unknown. The present study investigated
whether acute YM ingestion augments fat metabolism parameters of fatty acid oxidation (FAO) and energy
expenditure derived from FAO (EEFAO) during exercise with several intensities.
Methods: Fourteen healthy males and females were randomised in a repeated measures crossover experimental
design. All participants ingested either 1000 mg of YM or placebo capsules (PLC) 60 min before performing two
incremental exercise ergometry tests. Power output was initiated at and increased by 0.5 W.kg−1 of body weight
every 3 min stage, until reaching peak oxygen uptake _VO2 Peak
 
. Expired gases and stoichiometric indirect
calorimetry were used to analyse FAO and EEFAO. Capillary blood samples were collected and analysed for blood
lactate concentration (BLC) at rest and at each submaximal and maximal power output.
Results: YM significantly increased FAO and EEFAO by 24% in all submaximal exercise intensities below 70% of
_VO2 peak (p < 0.001, ANOVA main effects) with post hoc tests showing a higher FAO and EEFAO (p < 0.05) at the lower
exercise intensities (e.g. 0.26 ± 0.09 vs. 0.35 ± 0.10 and 0.25 ± 0.12 vs. 0.33 ± 0.11 g.min−1 at 40 and 50% of _VO2 peak
respectively). These changes were combined with a trend towards a decrease in BLC (P = 0.066), and without a
significant difference in _VO2 peak , peak power, peak RER, or peak BLC.
Conclusions: Acute YM ingestion augments the exercise dependent increase in FAO and EEFAO at submaximal
exercise intensities without negatively affecting maximal exercise performance, suggesting a potential role for YM
ingestion to increase the exercise effectiveness for weight loss and sports performance.
Keywords: Plant, Ingestion, Metabolism, Weight loss, Thermogenic
Introduction
Yerba Maté (YM), the dried leaves and branches of the
plant Illex Paraguariensis, is currently consumed by over
1 million people worldwide, traditionally by many South
American countries, and more recently in North
America and Europe in the form of YM tea beverage
made from the aqueous extracts of the dried leaves and
stem. The active ingredients of YM include polyphenols
and caffeoyl derivatives (caffeic acid, chlorogenic acid, 3,
4-Dicaffeoylquinic acid, 4, 5-Dicaffeoylquinic acid and
3,5-Dicaffeoylquinic acid), phytosterols and saponins
[1,2]. These active ingredients have been suggested to
explain several biomedical properties associated with
YM ingestion including anti-oxidant, vasodilatory, lipid
lowering properties, anti-mutagenic and anti-glycation
effects [3]. These properties have often accompanied
weight and fat loss and increased energy metabolism as
recently demonstrated in mice studies [4-7].
The reported effects in humans are limited to one
study that showed an increase in resting metabolic rate
and reduced respiratory quotient after prolonged resting
periods of 1–4 hrs, induced by acute YM ingestion [8].
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However, those resting effects may be further augmented
during exercise, especially considering that energy me-
tabolism is already stimulated as a result of increasing
exercise intensity. It is established that fatty acid oxida-
tion (FAO) predominantly contributes to energy expen-
diture (EE) at low and moderate exercise intensities and
that carbohydrate oxidation (CHO) predominates at
higher exercise intensities above anaerobic threshold
[9,10]. It has been shown that achieving higher absolute
FAO and higher EE derived from FAO (EEFAO) at a
given exercise intensity or power output, particularly
those associated with aerobic exercise training in the
low and moderate intensity domains, is associated with
improved metabolic health and enhanced endurance ex-
ercise performance outcomes [11-15]. Therefore, given
the suggested thermogenic effectiveness of YM at rest
[8], it remains unknown whether and how YM ingestion
affects FAO and its contribution to EE during exercise.
This study aims to investigate the acute effects of YM
ingestion on FAO and EE derived from FAO (EEFAO)
during exercise of varied intensities. It is hypothesised
that YM ingestion increases FAO and enhances EEFAO
during exercise.
Methods
Design and participants
The study followed a double-blind crossover repeated
measures experimental design. All environmental condi-
tions were maintained the same during all experimental
conditions (Mean ± SD: 20 ± 1°C, 775.6 ± 12 mmHg and
51.1 ± 6.1%) for air temperature, barometric pressure
and relative humidity respectively. The study gained in-
stitutional ethical approval and was carried out in ac-
cordance with the Declaration of Helsinki of the World
Medical Association and all participants gave their written
informed consent to participate. Sample size calculations
were based on achieving a large effect size based on the
least meaningful difference induced by thermogenic sup-
plements on EE in previous studies [16], and provided a
power of 90% for a significance alpha level of 5%.
The participants were fourteen healthy adults, seven
males and seven females [Mean ± SD: age = 20.8 ± 3.4 yr,
height = 171.8 ± 10.0 cm, body mass = 70.4 ± 11.3 kg, body
mass index (BMI; in kg.m−2) = 23.8 + 0.11]. Participants
were assigned randomly to each experimental condition
within a period of two weeks. Female participants were
studied in days 1 to 7 of their menstrual cycle to minimise
the influence of cyclical changes in female hormones.
All participants were screened prior to the start of the
testing in order to determine that they are free from illness
and any type of orthopaedic limitation or injury, and also
that they meet the exclusion criteria defined as follows: A)
History of any cardiovascular or respiratory disease,
hypertension, liver or kidney disease, musculoskeletal or
neuromuscular or neurological disease, autoimmune dis-
ease, cancer, peptic ulcers or anaemia. B) Taking medica-
tions, as well as a family history of heart problems, high
blood pressure, and/or stroke, and being pregnant or
breastfeeding. C) Consuming any ergogenic aid or above
habitual caffeine consumption rate (200 mg/day) for at
least one week prior to the study based on all types of caf-
feinated beverages (coffee, energy drinks, soft drinks,
caffeine supplements or medications). All Participants
refrained from taking any supplements for the duration of
the study and were instructed to refrain from strenuous
exercise or alcohol and caffeine consumption for at least
24 hours before each test. Participants have also com-
pleted a 24-hrs food diary and were asked to replicate it
before the second visit.
Experimental procedures and protocols
All participants reported to the Physiology Laboratory on
two separate occasions following 10 hrs overnight fast,
and each testing session (between 0700 and 1000) was
separated by at least three days within two weeks period.
Participants who had no previous laboratory experience
were habituated in a separate laboratory visit, which in-
cluded repeating the exercise and ingestion protocol
within similar laboratory conditions. Anthropometric
measurements included stature and body mass (Seca
Alpha, Hamburg, Germany). During each visit partici-
pants ingested either 1000 mg (2× 500 mg capsule) YM
or hydroxypropyl methylcellulose placebo empty capsules
(PLC). Two capsules with similar coatings of either YM
and PLC capsules were placed within an empty water cup
and taken in the same way with a 100 ml of water. The
YM capsules contained a standardised ground YM leaves
(batch number 0422009/2012) with a natural content of
approximately 1.5% caffeine (Rio Trading Company,
Brighton, United Kingdom). Immediately following the
ingestion, participants rested for 60 minutes in a semi-
recumbent position in quiet laboratory condition. For
the estimation of FAO and CHO at rest and during ex-
ercise, breath by breath cardiorespiratory measurements
included oxygen uptake _VO2
 
, carbon dioxide produc-
tion _VCO2
 
and respiratory exchange ratio (RER),
using an online gas analyzer (Metalyzer Cortex 3B,
Leipzig, Germany). The metabolic measurement system
was calibrated prior to each test as follows: flow sensor
and gas analyzers were calibrated using calibration gases
of known concentration (16% for O2, and 5% for CO2),
and for the gas volume a 3 liter volume calibration syr-
inge (Hans Rudolph, Kansas, USA) was used.
Exercise protocol
All participants followed an incremental exercise as-
sessment using an electromagnetically braked cycling
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ergometer (Schoberer Rad Messtechnik, SRM, Ergo,
Julich, Germany). The ergometer was calibrated before
use and similar cycling positions were applied in both
tests for each participant, which included adjusting the
handlebar and saddle height and distance, crank length
and toe clip positions during the first visit and re-applying
the same position in the following visit. The cycling
protocol consisted of three-minute incremental stages
that were initiated at and increased by 0.5 W.kg−1 of
body mass. Participants cycled at 60–70 rpm through-
out the whole test until volitional exhaustion defined
as meeting the at least two of _VO2peak
 
termination
criteria: RER value > 1.1, heart rate within 10 beats.min−1
of age-predicted maximum heart-rate, or achieving
levelling-off of _VO2 . Peak power (Ppeak) was calculated
as the highest power output achieved during the last
completed incremental stage, plus the fraction of time
spent in any final non-completed stage multiplied by
the power increment. Similar verbal encouragement
was provided to all participants throughout the exercise
tests.
All tests were followed by a sufficient cool down for at
least 20 min, in which participants consumed at least
200 ml of water, and instructed to stay hydrated and
consume at least 2 litres of water during the day of the
test.
Blood sampling
Capillary blood samples (5 μl) were collected from the
pin prick of the finger tip, at rest, during the last 30 s of
each incremental exercise stage and immediately after
exhaustion at min 1, 3 and 5. Blood samples were fur-
ther analyzed for blood lactate using a portable analyzer
(Lactate Pro LP1710, Arkray inc. Japan).
Data processing and statistical analysis
_VO2 , _VCO2 and RER were averaged for the last minute
of each 5 min of the 60 min rest, and averaged for the
last minute of each incremental stage. RER was calcu-
lated as _VCO2= _VO2
 
. FAO and CHO were estimated
using the stoichiometric indirect calorimetry equations
assuming minimal protein contribution during exercise
[17] (Eq. 1 and 2). Caloric equivalents were applied to
estimate EEFAO and EECHO.
FAO ¼ 1:695 _VO2−1:701 _VCO2 ð1Þ
CHO ¼ 4:585 _VCO2−3:226 _VO2 ð2Þ
All data were described as mean and standard deviation.
A mixed measure ANOVA (YM x power outputs) was
applied to detect the effects of YM ingestion on RER
and FAO, with YM supplement as within factors, and
stage power increments as between factors, and
Bonferroni post hoc test was applied to analyse the dif-
ferences at each power output increment. Paired t-test
was applied to detect the differences between YM and
PLC at baseline and at maximal exercise performance.
For all statistics SPSS V21 was used and the significance
level was set at p < 0.05.
Results
Following the 60 min rest after YM ingestion, no signifi-
cant difference was found for either resting BLC (1.4 ±
0.32 vs. 1.5 ± 0.30 mmol.l−1) or resting RER (0.82 ± 0.08
vs. 0.81 ± 0.05) for PLC vs. YM respectively.
However, during exercise YM significantly reduced
RER (P < 0.001, ANOVA main effects), (Figure 1) and
increased FAO (P < 0.001, ANOVA main effects),
(Figure 2). The YM effects on RER and on FAO were in-
dependent of the increase in power output (P < 0.001 in
both conditions) and there was no interaction effects be-
tween the power output increase and YM supplement
(Figures 1 and 2). Conversely, CHO was reduced in YM
compared with PLC (Figure 3).
In terms of energy expenditure contribution, irre-
spectively of exercise intensity increase (no interaction
effects) YM increased EEFAO (P < 0.001), and decreased
and EECHO (P < 0.01), (Table 1).
There was also a trend, though not significant towards a
reduced BLC (P = 0.066) in YM condition compared with
PLC (Figure 4) at submaximal exercise. However, at peak
level no difference was found in either peak BLC
(BLCpeak), _VO2peak , Ppeak or peak RER (RERpeak) in YM
compared with PLC (Table 2).
Discussion
The key finding of the present study is that YM inges-
tion augments FAO and reduces CHO reliance during
exercise, over a wide range of exercise intensities, par-
ticularly in the light and moderate domains that are
Figure 1 Respiratory exchange ratio (RER) at submaximal
intensities in YM compared with PLC (P < 0.001, ANOVA
main effects).
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known to be effective training intensities and are often
prescribed for a variety of population groups with the
aim of weight loss, disease prevention and improving en-
durance exercise performance [13-15,18]. Augmented
metabolic benefits of YM ingestion when combined with
exercise could consequently contribute to the prevention
and treatment of overweight and obesity associated
metabolic health risks including diabetes and hyperinsu-
linaemia, hypercholestrolaemia and cancer [19,20].
In both treatment conditions FAO was increased simi-
larly as a function of power output, but higher FAO was
found in the YM condition at exercise intensities below
70% of _VO2peak (Figures 1 and 2). Within this range of
exercise intensities, FAO is well known to be utilised as
a primary fuel source for energy expenditure (30-70%),
while CHO predominates at heavy exercise intensities
until reaching CHO saturation level (corresponding to
RER = 1) [9,10,12]. Therefore, increased FAO and
EEFAO with YM ingestion in the light and moderate ex-
ercise intensity domains may augment both exercise
dependent outcomes associated with those intensities
[11,14], and may augment metabolic and anti-adiposity
markers associated with YM ingestion, such as decreased
differentiation of pre-adipocytes and reduced accumula-
tion of lipids in adipocytes [3-5].
It is well documented that FAO and lipolysis increase
several fold during exercise than at rest [10,21,22], and
the present study is the first to demonstrate the positive
effects of YM ingestion during exercise, particularly
submaximal exercise, rather than at rest. Only one study
reported a reduction in RER during 1–4 hrs of rest in
healthy individuals who ingested 1 g of YM [8], which is
similar to the present study. In comparison, the present
study, using a similar dosage and following one hr rest,
found that the differences in RER in YM vs. PLC be-
come more prominent and significant during exercise
(Figure 1), which corresponded to 24% increase in both
FAO and EE derived from FAO (Table 1). This increase
proposes YM as a promoter of fat metabolism during
exercise.
The exercise induced metabolic effects found in the
present study could be attributed to a number of reasons
related to the major constituents of YM. Perhaps, the
main effects YM function found on FAO are explained
by central mechanisms and glycogen sparing of caffeine
[23], which is found to have the highest concentration of
1% to 2% (naturally occurring ~1.5% in the present study)
of dry weight of YM leaves and stem [24]. This caffeine
amount (approximately 80 mg) is considered low com-
pared with other multi-ingredient thermogenic supple-
ments that reported increased FAO and EE (only at rest)
where caffeine content exceeds 350 mg [25], which sug-
gests that other active ingredients may have contributed
to the present findings. The remaining reported com-
pounds of YM include saponins, which are attributed to
anti-lipolytic and hypocholestrolaemic properties when
administered chronically, and caffeoyl derivatives (caffeic
acid, chlorogenic acid, 3, 4-Dicaffeoylquinic acid, 4, 5-
Dicaffeoylquinic acid and 3, 5-Dicaffeoylquinic acid)
which are thought to have higher concentration compared
with green or black tea and to have mainly anti-oxidant
properties [1]. It has recently been shown that plasma
lipid profile (triglycerides, fatty acids and total cholesterol)
is ameliorated in mice fed with YM, combined with a posi-
tive effect on leptin’s central and peripheral induced feed-
back loop that regulates adipose tissues, energy balance
and EE [26]. However, it is difficult to link these mecha-
nisms with the acute effects during exercise in humans,
though recent studies have suggested an acute effect of ex-
ercise on changes in lipid profile [27], which could be aug-
mented by the ingestion of YM. It is also important to
note that YM has a number of amino acids (i.e. Glutamic
acid, Proline), minerals (P, Fe and Ca) and vitamins (C, B1
and B2) which have energy metabolism properties [1,3],
which could influence exercise metabolic outcomes [28],
though further research is required to determine their po-
tential relationship.
Figure 2 Fat oxidation rate (FAO) at submaximal intensities for
YM compared with placebo (P < 0.001, ANOVA main effects).
Figure 3 Carbohydrate oxidation rate (CHO) at submaximal
intensities for YM compared with placebo (P < 0.001, ANOVA
main effects).
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Perhaps the closest supplement to compare the found
increase in FAO contribution to total EE is green tea
(Camella Sinesis). This is due to several similar active in-
gredients especially the phenolic antioxidant content in
both YM and green tea, though catechin polyphenols
have been shown to be highly abundant in green tea,
while saponins and some caffeoyl derivatives are abun-
dant in YM [1,3]. The present study administered 1 g of
YM, almost half of the dosage of 1.8 g of green tea ex-
tract (no caffeine) administered by Venables et al.
[14,16], and close to the dose of 525 mg of green tea ex-
tracts (375 mg catechins and 150 mg caffeine) with simi-
lar percentage of 1% of caffeine administered within
24 hrs by Dulloo et al. [19,29]. In comparison to the ef-
fects on EE reported in these studies, and only consider-
ing the similar active ingredients to those found in YM,
the relatively small dosage of YM administered in the
present study seem to be effective in further stimulating
FAO and EE contribution to total FAO during exercise
intensities in the moderate domain (Table 1), which is in
agreement with the latter studies. However, the increase
in FAO found in the present study of 0.09 g.min−1 is
higher than a ~0.06 g.min−1 increase with green tea in-
gestion [16] and is close to 0.11 g.min−1 that was re-
ported with an exercise training intervention [14].
Comparative analysis of YM and green tea that have
used several measurement techniques have demon-
strated higher content of active ingredients (approxi-
mately 50 more active ingredients) than those found in
green tea [1,3], which suggest a potential important role
for YM in metabolic health, and future research may
elicit the potential health outcomes of combining YM
with exercise training.
The study relied on an effective exercise protocol that
is known reflect a wide range of exercise intensities, in-
cluding effective training exercise intensities in the light
and moderate domains (corresponding to RER ≤ 1)
which are considered effective for a number of metabolic
health, weight loss and cardiovascular risk reduction
outcomes in a variety of population and age groups
[14,30-32]. For example, training at intensities that cor-
respond to maximal FAO has been associated with im-
proved insulin sensitivity and fat loss [14]. Increased
reliance on EE from FAO energy fuel sources with ap-
proximately 0.5-1.0 kcal.min−1 increase (P < 0.01) in EE
from FAO and reduction in EE from CHO as induced
by YM compared with PLC (Table 1) reflects a rightward
shift in the intensity at the cross-over point defined as
the power output when EE from CHO fuel sources pre-
dominates over EE from FAO, and hence it reflects an
improvement in muscle glycogen sparing capacity, which
is a known determining factor for endurance exercise
performance [12]. Even though assessing YM effective-
ness when combined with exercise training requires fur-
ther investigations, the present study suggest a potential
role for YM in increasing the training effectiveness at
the cross-over point intensities [33,34], that have been
tested within this study.
The YM dependent reduction (though non-significant)
in BLC during exercise (Figure 4), is indicative of an ef-
fect on exercise tolerance and delaying fatigue mecha-
nisms [35], are also in line with lower reliance on CHO
as an energy fuel and increased reliance on FAO at exer-
cise intensities corresponding to RER < 1 (Figure 3),
which are all in the submaximal intensity domain, and
agree with the dynamic interrelationship between BLC,
CHO and FAO [11,12].
The present study relied on well-established metabolic
markers that are based on capillary blood and cardiore-
spiratory gas measurements to demonstrate the YM ef-
fects during carefully selected exercise protocol with
several intensity domains [11,15,18,34]. However, future
studies need to further investigate the blood-based fat
Table 1 Energy expenditure contributions (Mean ± SD) from FAO (EEFAO) and CHO (EECHO) at submaximal intensities in
YM compared with PLC (all P < 0.001, ANOVA main effects)
Exercise Intensity
% _VO2peak
  EEFAO-PLC kJ. min
−1
(kcal.min−1)
EEFAO-YM kJ. min
−1
(kcal.min−1)
EECHO-PLC kJ. min
−1
(kcal.min−1)
EECHO-YM kJ. min
−1
(kcal.min−1)
40 9.97 ± 3.27 (2.38 ± 0.78) 13.08 ± 3.73 (3.13 ± 0.90) 9.92 ± 3.27 (2.37 ± 0.78) 6.15 ± 4.19 (1.47 ± 1.00)
50 9.56 ± 4.70 (2.28 ± 1.12) 12.43 ± 4.22 (2.97 ± 1.00) 16.74 ± 5.57 (4.00 ± 1.33) 12.60 ± 4.06 (3.01 ± 0.97)
60 6.04 ± 5.82 (1.44 ± 1.39) 9.56 ± 5.92 (2.28 ± 1.41) 27.54 ± 7.95 (6.58 ± 1.90) 22.60 ± 8.00 (5.40 ± 1.91)
70 0.78 ± 6.68 (0.10 ± 1.00) 4.01 ± 7.69 (0.96 ± 1.83) 42.11 ± 9.33 (10.06 ± 2.23) 37.13 ± 13.48 (8.87 ± 3.22)
Figure 4 Blood lactate concentration (BLC) at submaximal
intensities for YM compared with placebo (P = 0.066, ANOVA
main effects).
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metabolic variables such as glycerol and non-esterified
fatty acids, which would confirm the mechanisms behind
any putative increase in lipid mobilisation and utilisa-
tion. Moreover, assessing both YM and plasma lipids
post-ingestion for the active ingredients (eg. caffeic acid,
chlorogenic acid, 3, 4-Dicaffeoylquinic acid, 4, 5-
Dicaffeoylquinic acid and 3,5-Dicaffeoylquinic acid,
phytosterols and saponins) would confirm the bioavail-
ability of YM’s active ingredients.
It is also important to note that the YM effects on
FAO and EE within the present protocol, particularly at
sub-maximal intensities, may need to be further investi-
gated using a variety of exercise protocols before any ex-
ercise training recommendations can be drawn. In
particular, combining YM supplementation with supra-
maximal and sprint type protocols, and training studies
that utilises the recently publicised high-intensity inter-
val training could be further investigated.
To conclude, acute ingestion of YM before exercise
enhances fat metabolism during light and moderate ex-
ercise intensities, without negatively affecting maximal
performance. These effects also suggest a glycogen spar-
ing potential for exercise performance. Further research
is required on specific long-term strategies that combine
YM with exercise to accelerate weight loss outcomes
and potentially enhance metabolic health outcomes.
Abbreviations
YM: Yerba Maté; FAO: Fatty acid oxidation; CHO: Carbohydrate oxidation;
EE: Energy expenditure; EEFAO: Energy expenditure derived from FAO;
EECHO: Energy derived from CHO; PLC: Placebo capsules; _VO2 : oxygen uptake;
_VCO2 : carbon dioxide production; RER: Respiratory exchange ratio;
_VO2 peak : peak oxygen uptake; BLC: Blood lactate concentration; BMI: Body Mass
Index; BLCpeak: peak blood lactate concentration; Ppeak: Peak power output;
RERpeak: peak respiratory exchange ratio.
Competing interest
The author declare that they have no competing interests.
Author contributions
AA designed this study, analysed the data, prepared the figures, and
prepared and finalized the manuscript.
Acknowledgements
The author would like to thank all volunteers who took part in this study.
The author declares no conflicts of interest.
Received: 3 July 2014 Accepted: 28 August 2014
Published: 2 September 2014
References
1. Heck CI, de Mejia EG: Yerba Mate Tea (Ilex paraguariensis): a
comprehensive review on chemistry, health implications, and
technological considerations. J Food Sci 2007, 72(9):R138–R151.
2. Bastos DHM, De Oliveira DM, Matsumoto RLT, Carvalho PO, Ribeiro ML:
Yerba maté: pharmacological properties, research and biotechnology.
Med Aromat Plant Sci Biotech 2007, 1:37–46.
3. Bracesco N, Sanchez AG, Contreras V, Gugliucci A: Recent advances on Ilex
paraguariensis research: minireview. J Ethnopharmacol 2011, 136(3):378–384.
4. Borges MC, Vinolo MA, Nakajima K, de Castro IA, Bastos DH, Borelli P, Fock RA,
Tirapegui J, Curi R, Rogero MM: The effect of mate tea (Ilex paraguariensis)
on metabolic and inflammatory parameters in high-fat diet-fed Wistar rats.
Int J Food Sci Nutr 2013, 64(5):561–569.
5. Kang YR, Lee HY, Kim JH, Moon DI, Seo MY, Park SH, Choi KH, Kim CR, Kim
SH, Oh JH, Cho SW, Kim SY, Kim MG, Chae SW, Kim O, Oh HG: Anti-obesity
and anti-diabetic effects of Yerba Mate (Ilex paraguariensis) in C57BL/6 J
mice fed a high-fat diet. Lab Anim Res 2012, 28(1):23–29.
6. Arçari DP, Bartchewsky W Jr, dos Santos TW, Oliveira KA, DeOliveira CC,
Gotardo ÉM, Pedrazzoli J Jr, Gambero A, Ferraz LF, Carvalho Pde O, Ribeiro
ML: Anti-inflammatory effects of yerba maté extract (Ilex paraguariensis)
ameliorate insulin resistance in mice with high fat diet-induced obesity.
Mol Cell Endocrinol 2011, 335(2):110–115.
7. Arçari DP, Bartchewsky W, dos Santos TW, Oliveira KA, Funck A,
Pedrazzoli J, de Souza MF, Saad MJ, Bastos DH, Gambero A, Carvalho Pde
O, Ribeiro ML: Antiobesity effects of yerba maté extract (Ilex
paraguariensis) in high-fat diet-induced obese mice. Obesity (Silver
Spring) 2009, 17(12):2127–2133.
8. Martinet A, Hostettmann K, Schutz Y: Thermogenic effects of commercially
available plant preparations aimed at treating human obesity.
Phytomedicine 1999, 6(4):231–238.
9. Romijn JA, Coyle EF, Sidossis LS, Gastaldelli A, Horowitz JF, Endert E,
Wolfe RR: Regulation of endogenous fat and carbohydrate metabolism in
relation to exercise intensity and duration. Am J Physiol 1993,
265(3 Pt 1):E380–E391.
10. Van Loon LJ, Greenhaff PL, Constantin-Teodosiu D, Saris WH, Wagenmakers
AJ: The effects of increasing exercise intensity on muscle fuel utilisation
in humans. J Physiol 2001, 536:295–304.
11. Alkhatib A: Predictors of exercise performance. In Trends in Human
Performance Research. Edited by Duncan MJ, Lyons M. New York: NOVA
Science Publisher; 2010:168–183.
12. Brooks GA, Mercier J: Balance of carbohydrate and lipid utilization
during exercise: the “crossover” concept. J Appl Physiol 1994,
76(6):2253–2261.
13. Pérez-Martin A, Dumortier M, Raynaud E, Burn JF, Fédou C, Bringer J,
Mercier J: Balance of substrate oxidation during submaximal exercise in
lean and obese people. Diabetes Metab 2001, 27(4 Pt 1):466–474.
14. Venables MC, Jeukendrup AE: Endurance training and obesity: effect on
substrate metabolism and insulin sensitivity. Med Sci Sports Exerc 2008,
40(3):495–502.
15. Croci I, Byrne NM, Choquette S, Hills AP, Chachay VS, Clouston AD,
O’Moore-Sullivan TM, Macdonald GA, Prins JB, Hickman IJ: Whole-body
substrate metabolism is associated with disease severity in patients with
non-alcoholic fatty liver disease. Gut 2013, 62(11):1625–1633.
16. Venables MC, Hulston CJ, Cox HR, Jeukendrup AE: Green tea extract
ingestion, fat oxidation, and glucose tolerance in healthy humans. Am J
Clin Nutr 2009, 87(3):778–784.
17. Péronnet F, Massicotte D: Table of nonprotein respiratory quotient: an
update. Can J Sport Sci 1991, 16(1):23–29.
18. Achten J, Gleeson M, Jeukendrup AE: Determination of the exercise
intensity that elicits maximal fat oxidation. Med Sci Sports Exerc 2002,
34(1):92–97.
19. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, Lang
CC, Rumboldt Z, Onen CL, Lisheng L, Tanomsup S, Wangai P Jr, Razak F,
Sharma AM, Anand SS: Obesity and the risk of myocardial infarction in
27,000 participants from 52 countries: a case–control study. Lancet 2005,
366(9497):1640–1649.
20. Blair SN, Brodney S: Effects of physical inactivity and obesity on morbidity
and mortality: current evidence and research issues. Med Sci Sports Exerc
1999, 31(11 Suppl):S646–S662.
21. Arner P, Kriegholm E, Engfeldt P, Bolinder J: Adrenergic regulation of
lipolysis in situ at rest and during exercise. J Clin Invest 1990, 85:893–898.
Table 2 Maximal data (Mean ± SD) in YM compared with
PLC
Ppeak (W) _VO2peak
(ml.kg−1.min−1)
BLCpeak
(mmol.l−1)
RERpeak
YM PLC YM PLC YM PLC YM PLC
222.3 ±
59.8
221.8 ±
66.8
38.8 ±
8.4
38.1 ±
8.7
9.5 ±
2.5
9.1 ±
2.7
1.14 ±
0.05
1.11 ±
0.07
Alkhatib Nutrition & Metabolism 2014, 11:42 Page 6 of 7
http://www.nutritionandmetabolism.com/content/11/1/42
22. Wolfe RR, Klein S, Carraro F, Weber JM: Role of triglyceride-fatty acid cycle
in controlling fat metabolism in humans during and after exercise. Am J
Physiol 1990, 258:E382–E389.
23. Graham TE: Caffeine and exercise: metabolism, endurance and
performance. Sports Med 2001, 31(11):785–807.
24. Ito E, Crozier A, Ashihara H: Theophylline metabolism in higher plants.
Biochim Biophys Acta 1997, 1336(2):323–330.
25. Outlaw J, Wilborn C, Smith A, Urbina S, Hayward S, Foster C, Wells S,
Wildman R, Taylor L: Effects of ingestion of a commercially available
thermogenic dietary supplement on resting energy expenditure, mood
state and cardiovascular measures. J Int Soc Sports Nutr 2013, 10(1):25.
26. Hussein GM, Matsuda H, Nakamura S, Hamao M, Akiyama T, Tamura K,
Yoshikawa M: Mate tea (Ilex paraguariensis) promotes satiety and body
weight lowering in mice: involvement of glucagon-like peptide-1. Biol
Pharm Bull 2011, 34(12):1849–1855.
27. Shaheen HA, Alpert PT, Navalta J, Tandy RD, Young JC, Santo AS: The effect
of acute endurance exercise on lipoproteins: a comparison of the
nuclear magnetic resonance technique with the conventional lipid
profile in healthy men. Appl Physiol Nutr Metab 2014, 39(2):233–237.
28. Kreider RB, Wilborn CD, Taylor L, Campbell B, Almada AL, Collins R, Cooke
M, Earnest CP, Greenwood M, Kalman DS, Kerksick CM, Kleiner SM, Leutholtz
B, Lopez H, Lowery LM, Mendel R, Smith A, Spano M, Wildman R,
Willoughby DS, Ziegenfuss TN, Antonio J: ISSN exercise & sport nutrition
review: research & recommendations. J Int Soc Sports Nutr 2010, 7:7.
29. Dulloo AG, Duret C, Rohrer D, Girardier L, Mensi N, Fathi M, Chantre P,
Vandermander J: Efficacy of a green tea extract rich in catechin
polyphenols and caffeine in increasing 24-h energy expenditure and fat
oxidation in humans. Am J Clin Nutr 1999, 70(6):1040–1045.
30. Carnier J, De Mello MT, Ackel-DElia C, Corgosinho FC, Campos RM, de Sanches
PL, Masquio DC, Bueno CR Jr, Ganen Ade P, Martins AC, Caranti DA, Tock L,
Clemente AP, Tufik S, Dâmaso AR: Aerobic training (AT) is more effective
than aerobic plus resistance training (AT+RT) to improve anorexigenic/
orexigenic factors in obese adolescents. Appetite 2013, 69:168–173.
31. Donnelly JE, Honas JJ, Smith BK, Mayo MS, Gibson CA, Sullivan DK, Lee J,
Herrmann SD, Lambourne K, Washburn RA: Aerobic exercise alone results
in clinically significant weight loss for men and women: midwest
exercise trial 2. Obesity (Silver Spring) 2013, 21(3):E219–E228.
32. Alkhatib A, Klonizakis M: Effects of Exercise Training and Mediterranean
Diet on Reducing Post-Menopausal Vascular Risk. Clin Hemorheol Microcirc
2014, 57(1):33–47.
33. Billat V, Sirvent P, Lepretre PM, Koralsztein JP: Training effect on
performance, substrate balance and blood lactate concentration at
maximal lactate steady state in master endurance-runners. Pflugers Arch
2004, 447(6):875–883.
34. Venables MC, Achten J, Jeukendrup AE: Determinants of fat oxidation
during exercise in healthy men and women: a cross-sectional study.
J Appl Physiol 2005, 98(1):160–167.
35. Brooks GA: Anaerobic threshold: review of the concept and directions for
future research. Med Sci Sports Exerc 1985, 17(1):22–34.
doi:10.1186/1743-7075-11-42
Cite this article as: Alkhatib: Yerba Maté (Illex Paraguariensis) ingestion
augments fat oxidation and energy expenditure during exercise at
various submaximal intensities. Nutrition & Metabolism 2014 11:42.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Alkhatib Nutrition & Metabolism 2014, 11:42 Page 7 of 7
http://www.nutritionandmetabolism.com/content/11/1/42
